Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Agrematch Ltd. is currently handling 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This single active application is assigned to a distinct examiner and is being processed in a distinct art unit. This reflects a concentrated prosecution effort for the company's current portfolio. The busiest examiner for the firm is ROBERTS, LEZAH, who is managing 1 busiest examiner pending action.
The 1 pending office action is entirely under the review of a distinct examiner, making this individual the primary point of contact for the company's active matters. The use of a distinct art unit indicates that the pending technology is focused within a specific category of the Biotechnology & Pharmaceuticals sector. This structure allows the company to focus its resources on responding to the specific requirements of ROBERTS, LEZAH without the complexity of managing multiple examiners or art units.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ROBERTS, LEZAH | 1 | 48.6% | +35.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18577309 | HERBICIDAL COMPOSITIONS | ROBERTS, LEZAH | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18577309 | HERBICIDAL COMPOSITIONS | ROBERTS, LEZAH | — |
| Art Unit | Apps |
|---|---|
| 1612 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18577309 | HERBICIDAL COMPOSITIONS | ROBERTS, LEZAH | 1612 | §102§103§112 | Non-Final OA | — | Pending | Jan 08, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialAgrematch Ltd. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
Lezah Roberts has the most, with 1 of Agrematch Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.